RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model

Oncogene

Volumn 33, Issue 7, 2014, Pages 882-890

  Byrne, F L ^a   Yang, L ^a   Phillips, P A ^a   Hansford, L M ^b   Fletcher, J I ^a   Ormandy, C J ^c   McCarroll, J A ^a,d   Kavallaris, M ^a,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

cofilin; cytoskeleton; orthotopic xenograft; tubulin

Indexed keywords

ACTIN DEPOLYMERIZING FACTORS; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CYTOSKELETON; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RHO-ASSOCIATED KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; STATHMIN; TUMOR BURDEN;

EID: 84894064647     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.11     Document Type: Article

References (40)

1. Gutierrez JC, Fischer AC, Sola JE, Perez EA, Koniaris LG. Markedly improving survival of neuroblastoma: a 30-year analysis of 1646 patients. Pediatr Surg Int 2007; 23: 637-646.
2. Ara T, DeClerck YA. Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 2006; 25: 645-657.
3. DuBois SG, Kalika Y, Lukens JN, Brodeur GM, Seeger RC, Atkinson JB et al. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 1999; 21: 181-189.
4. DuBois SG, London WB, Zhang Y, Matthay KK, Monclair T, Ambros PF et al. Lung metastases in neuroblastoma at initial diagnosis: a report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer 2008; 51: 589-592.
5. Insall RH, Machesky LM. Actin dynamics at the leading edge: from simple machinery to complex networks. Dev Cell 2009; 17: 310-322.
6. Torka R, Thuma F, Herzog V, Kirfel G. ROCK signaling mediates the adoption of different modes of migration and invasion in human mammary epithelial tumor cells. Exp Cell Res 2006; 312: 3857-3871.
7. Kadir S, Astin JW, Tahtamouni L, Martin P, Nobes CD. Microtubule remodelling is required for the front-rear polarity switch during contact inhibition of locomotion. J Cell Sci 2011; 124: 2642-2653.
8. Curmi PA, Gavet O, Charbaut E, Ozon S, Lachkar-Colmerauer S, Manceau V et al. Stathmin and its phosphoprotein family: general properties, biochemical and functional interaction with tubulin. Cell Struct Funct 1999; 24: 345-357.
9. Belletti B, Nicoloso MS, Schiappacassi M, Berton S, Lovat F, Wolf K et al. Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell 2008; 19: 2003-2013.
10. Hsieh SY, Huang SF, Yu MC, Yeh TS, Chen TC, Lin YJ et al. Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Mol Carcinog 2010; 49: 476-487.
11. Jeon TY, Han ME, Lee YW, Lee YS, Kim GH, Song GA et al. Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells. Br J Cancer 2010; 102: 710-718.
12. Saal LH, Johansson P, Holm K, Gruvberger-Saal SK, She QB, Maurer M et al. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc Natl Acad Sci USA 2007; 104: 7564-7569.
13. Trovik J, Wik E, Stefansson IM, Marcickiewicz J, Tingulstad S, Staff AC et al. Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer. Clin Cancer Res 2011; 17: 3368-3377.
14. Sadow PM, Rumilla KM, Erickson LA, Lloyd RV. Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors. Endocr Pathol 2008; 19: 97-103.
15. Hailat N, Strahler J, Melhem R, Zhu XX, Brodeur G, Seeger RC et al. N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18). Oncogene 1990; 5: 1615-1618.
16. Campostrini N, Pascali J, Hamdan M, Astner H, Marimpietri D, Pastorino F et al. Proteomic analysis of an orthotopic neuroblastoma xenograft animal model. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 808: 279-286.
17. Don S, Verrills NM, Liaw TY, Liu ML, Norris MD, Haber M et al. Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugs. Mol Cancer Ther 2004; 3: 1137-1146.
18. Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 2007; 1773: 642-652.
19. Gutjahr MC, Rossy J, Niggli V. Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells. Exp Cell Res 2005; 308: 422-438.
20. Narumiya S, Ishizaki T, Uehata M. Use and properties of ROCK-specific inhibitor Y-27632. Methods Enzymol 2000; 325: 273-284.
21. Tamura M, Nakao H, Yoshizaki H, Shiratsuchi M, Shigyo H, Yamada H et al. Development of specific Rho-kinase inhibitors and their clinical application. Biochim Biophys Acta 2005; 1754: 245-252.
22. Salvesen HB, Carter SL, Mannelqvist M, Dutt A, Getz G, Stefansson IM et al. Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proc Natl Acad Sci USA 2009; 106: 4834-4839.
23. Singer S, Malz M, Herpel E, Warth A, Bissinger M, Keith M et al. Coordinated expression of stathmin family members by far upstream sequence elementbinding protein-1 increases motility in non-small cell lung cancer. Cancer Res 2009; 69: 2234-2243.
24. Yuan RH, Jeng YM, Chen HL, Lai PL, Pan HW, Hsieh FJ et al. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma. J Pathol 2006; 209: 549-558.
25. Scott RW, Hooper S, Crighton D, Li A, Konig I, Munro J et al. LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. J Cell Biol 2010; 191: 169-185.
26. Bernard O. Lim kinases, regulators of actin dynamics. Int J Biochem Cell Biol 2007; 39: 1071-1076.
27. Balasubramani M, Nakao C, Uechi GT, Cardamone J, Kamath K, Leslie KL et al. Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresis. Mutat Res 2011; 722: 154-164.
28. Belletti B, Pellizzari I, Berton S, Fabris L, Wolf K, Lovat F et al. p27kip1 controls cell morphology and motility by regulating microtubule- dependent lipid raft recycling. Mol Cell Biol 2010; 30: 2229-2240.
29. Takesono A, Heasman SJ, Wojciak-Stothard B, Garg R, Ridley AJ. Microtubules regulate migratory polarity through Rho/ROCK signaling in T cells. PLoS ONE 2010; 5: e8774.
30. Wittmann T, Waterman-Storer CM. Cell motility: can Rho GTPases and microtubules point the way? J Cell Sci 2001; 114: 3795-3803.
31. Takahashi K, Suzuki K. Membrane transport of WAVE2 and lamellipodia formation require Pak1 that mediates phosphorylation and recruitment of stathmin/Op18 to Pak1-WAVE2-kinesin complex. Cell Signal 2009; 21: 695-703.
32. Takahashi K, Tanaka T, Suzuki K. Directional control of WAVE2 membrane targeting by EB1 and phosphatidylinositol 3,4,5-triphosphate. Cell Signal 2010; 22: 510-518.
33. Yilmaz M, Christofori G. Mechanisms of motility in metastasizing cells. Mol Cancer Res 2010; 8: 629-642.
34. Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P et al. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 2005; 7: 51-63.
35. Nevo I, Sagi-Assif O, Edry Botzer L, Amar D, Maman S, Kariv N et al. Generation and characterization of novel local and metastatic human neuroblastoma variants. Neoplasia 2008; 10: 816-827.
36. Khanna C, Jaboin JJ, Drakos E, Tsokos M, Thiele CJ. Biologically relevant orthotopic neuroblastoma xenograft models: primary adrenal tumor growth and spontaneous distant metastasis. In Vivo 2002; 16: 77-85.
37. Henriksson KC, Almgren MA, Thurlow R, Varki NM, Chang CL. A fluorescent orthotopic mouse model for reliable measurement and genetic modulation of human neuroblastoma metastasis. Clin Exp Metastasis 2004; 21: 563-570.
38. McCarroll JA, Gan PP, Liu M, Kavallaris M. betaIII-tubulin is a multifunctional protein involved in drug sensitivity and tumorigenesis in non-small cell lung cancer. Cancer Res 2010; 70: 4995-5003.
39. Phillips PA, Wu MJ, Kumar RK, Doherty E, McCarroll JA, Park S et al. Cell migration: a novel aspect of pancreatic stellate cell biology. Gut 2003; 52: 677-682.
40. Ponomarev V, Doubrovin M, Serganova I, Vider J, Shavrin A, Beresten T et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imaging 2004; 31: 740-751.